EICHORCondition: Recurrent, Refractory, or High Risk Leukemias · Matched Targeted Therapy · Sponsor: Dana-Farber Cancer Institute
This research study is seeking to gain new knowledge about Recurrent, Refractory, or High Risk Leukemias in children and young adults. This study is evaluating the use of specialized testing called leukemia profiling. Once the profiling is performed, the results are evaluated by an expert panel of physicians, scientists and pharmacists. This may result in a recommendation for a specific cancer therapy or a clinical trial called matched targeted therapy (MTT). The results of the leukemia profiling and, if applicable, the MTT recommendation will be communicated to the participant's primary oncologist.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| UCSF Helen Diller Family Comprehensive Cancer Center | San Francisco, California, United States | — |
| Children's Hospital Colorado | Aurora, Colorado, United States | — |
| Children's Healthcare of Atlanta | Atlanta, Georgia, United States | — |
| The University of Chicago | Chicago, Illinois, United States | — |
| Johns Hopkins Hospital | Baltimore, Maryland, United States | — |
| Dana Farber Cancer Institute | Boston, Massachusetts, United States | — |
| Children's Hospital's and Clinics of Minnesota | Minneapolis, Minnesota, United States | — |
| Washington University at St. Louis School of Medicine | St Louis, Missouri, United States | — |
| Roswell Park Comprehensive Cancer Center | Buffalo, New York, United States | — |
| Columbia University Medical Center | New York, New York, United States | — |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | — |
| The Children's Hospital at Montefiore | The Bronx, New York, United States | — |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02670525